Seeing Is Believing

Currently out of the existing stock ratings of Bruce Nudell, 30 are a BUY (85.71%), 5 are a HOLD (14.29%).
Analyst Bruce Nudell, carries an average stock price target met ratio of 75% that have a potential upside of 19.97% achieved within 347 days. Previously, Bruce Nudell worked at TRUIST, CREDIT SUISSE.
Bruce Nudell’s has documented 77 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABMD, ABIOMED at 14-May-2019.
Analyst best performing recommendations are on AXNX (AXONICS MODULATION TECHNOLOGIES).
The best stock recommendation documented was for EW (EDWARDS LIFESCIENCES CORP) at 8/10/2018. The price target of $56.67 was fulfilled within 47 days with a profit of $10.65 (23.14%) receiving and performance score of 4.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 31-Jul-2026
$28
$1.84 (7.03%)
$17
Hold Since 28-Oct-2022
$23
$-3.16 (-12.08%)
$33
Hold Since 08-Oct-2024
$29
$2.84 (10.86%)
$24
Hold Since 30-Oct-2025
$28
$1.84 (7.03%)
$24
Hold Since 28-Jul-2026
$25
$-1.16 (-4.43%)
$15
What Year was the first public recommendation made by Bruce Nudell?